{"transactions":[{"id":1729318,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-27T23:18:31.000Z","date":"2023-11-22","kind":"sale","planned":false,"acquired":false,"shares":3464,"price":43.3367,"value":150118.3288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":83342,"source":{"system":"sec-edgar","filing":"0001610717-23-000367","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000367/form4.xml","form_type":"4"}},{"id":1730695,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-11-22T21:30:46.000Z","date":"2023-11-20","kind":"sale","planned":false,"acquired":false,"shares":14718,"price":42.0909,"value":619493.8662,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $42.05 to $42.26. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 271 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 14, 2023."}],"balance_after":86806,"source":{"system":"sec-edgar","filing":"0001610717-23-000361","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000361/form4.xml","form_type":"4"}},{"id":1797355,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-08-24T21:08:53.000Z","date":"2023-08-22","kind":"sale","planned":false,"acquired":false,"shares":9699,"price":45.7811,"value":444030.8889,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":101253,"source":{"system":"sec-edgar","filing":"0001610717-23-000236","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000236/form4.xml","form_type":"4"}},{"id":1877607,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-05-25T21:49:01.000Z","date":"2023-05-23","kind":"sale","planned":false,"acquired":false,"shares":316,"price":55.0653,"value":17400.6348,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 874 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023."}],"balance_after":110952,"source":{"system":"sec-edgar","filing":"0001610717-23-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000161071723000065/form4.xml","form_type":"4"}},{"id":1939915,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Performance-based Restricted Stock Units","published_at":"2023-03-23T22:25:40.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":7278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each Performance-Based Restricted Stock Unit (\"PSU\") represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/3rd of the PSUs shall vest upon the Issuer's Class A Common Stock achieving each of three escalating stock price milestones, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":7278,"derivative":{"expiration_date":"2028-04-01","underlying":"Class A Common Stock","underlying_shares":7278},"source":{"system":"sec-edgar","filing":"0001140361-23-013503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013503/form4.xml","form_type":"4"}},{"id":1939914,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-03-23T22:25:40.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":14555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the total number of shares subject to the option vest on each monthly anniversary measured from April 1, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":14555,"derivative":{"exercise_price":50.1,"expiration_date":"2033-03-21","underlying":"Class A Common Stock","underlying_shares":14555},"source":{"system":"sec-edgar","filing":"0001140361-23-013503","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013503/form4.xml","form_type":"4"}},{"id":1939913,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2023-03-23T22:25:40.000Z","date":"2023-03-21","kind":"grant","planned":false,"acquired":true,"shares":14555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/16th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2023, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":110394,"source":{"system":"sec-edgar","filing":"0001140361-23-013503","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000114036123013503/form4.xml","form_type":"4"}},{"id":2156875,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-09-16T21:32:22.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":239596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to the option vest on the one-year anniversary measured from July 27, 2022, and 1/48th of the shares vest monthly thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":239596,"derivative":{"exercise_price":33.67,"expiration_date":"2032-09-14","underlying":"Class A Common Stock","underlying_shares":239596},"source":{"system":"sec-edgar","filing":"0001567619-22-017561","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922017561/doc1.xml","form_type":"4"}},{"id":2156874,"issuer":{"id":2172,"kind":"organization","name":"10x Genomics, Inc.","symbol":"TXG"},"owners":[{"id":107947,"kind":"person","name":"Wilbur James","position":1,"cik":"0001940931","reported_name":"Wilbur James","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2022-09-16T21:32:22.000Z","date":"2022-09-14","kind":"grant","acquired":true,"shares":95839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 25% of the RSUs vest on the one-year anniversary measured from August 21, 2022, and 1/16th of the RSUs vest quarterly thereafter, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":95839,"source":{"system":"sec-edgar","filing":"0001567619-22-017561","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1770787/000156761922017561/doc1.xml","form_type":"4"}}]}